← Back to Clinical Trials
Recruiting Phase 1, Phase 2 NCT06410001

CE-STAND: Cervical Epidural STimulation After Neurologic Damage

Trial Parameters

Condition Spinal Cord Injury
Sponsor University of Minnesota
Study Type INTERVENTIONAL
Phase Phase 1, Phase 2
Enrollment 36
Sex ALL
Min Age 22 Years
Max Age N/A
Start Date 2026-03-15
Completion 2030-05-31
Interventions
Epidural Spinal Cord Stimulation System

Brief Summary

CE-STAND aims to address three areas under-represented in research: chronic, cervical, and autonomic dysfunction. It is both significant and highly impactful, as treating autonomic dysfunction could substantially improve function and quality of life (QoL) in chronic cervical SCI patients.

Eligibility Criteria

Inclusion Criteria: * Twenty two years of age or older * Able to undergo the informed consent/assent process * Stable, motor-complete SCI * Discrete SCI between C4 and C7 (upper extremity weakness) * ASIA A or B SCI Classification * Medically stable in the judgment of the PI * Intact segmental reflexes below the lesion of injury * Greater than 1 year since initial injury and at least 6 months from any required spinal instrumentation * Normal or corrected-to-normal vision to accurately perceive visual stimuli on the N-back task screen, and sufficient hearing ability to accurately perceive auditory stimuli during the task * Willing to attend all scheduled appointments Exclusion Criteria: * Diseases and conditions that would increase the morbidity and mortality of this surgery such as cardiopulmonary. * Individuals who require respiratory support, including ongoing or intermittent use of a ventilator and/or diaphragmatic pacer * Inability to withhold antiplatelet/anticoagulation agents pe

Related Trials